Therapie der chronischen Hepatitis C mit Interferon alpha 2a und Amantadin:
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | German |
| Veröffentlicht: |
2004
|
| Schlagworte: | |
| Beschreibung: | München, Techn. Univ., Diss., 2004 |
| Beschreibung: | IV, 128 Bl. graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV019817395 | ||
| 003 | DE-604 | ||
| 005 | 20060220 | ||
| 007 | t | ||
| 008 | 050520s2004 d||| m||| 00||| ger d | ||
| 035 | |a (OCoLC)163395264 | ||
| 035 | |a (DE-599)BVBBV019817395 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a ger | |
| 049 | |a DE-91 |a DE-12 | ||
| 084 | |a MED 970d |2 stub | ||
| 084 | |a MED 403d |2 stub | ||
| 084 | |a MED 430d |2 stub | ||
| 100 | 1 | |a Matzner, Tobias |d 1976- |e Verfasser |0 (DE-588)129939595 |4 aut | |
| 245 | 1 | 0 | |a Therapie der chronischen Hepatitis C mit Interferon alpha 2a und Amantadin |c Tobias Matzner |
| 264 | 1 | |c 2004 | |
| 300 | |a IV, 128 Bl. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 500 | |a München, Techn. Univ., Diss., 2004 | ||
| 650 | 0 | 7 | |a Amantadin |0 (DE-588)4201880-8 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Interferon |g alpha-2a- |0 (DE-588)4353085-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Hepatitis C |0 (DE-588)4262007-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Kombinationstherapie |0 (DE-588)4194534-7 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4113937-9 |a Hochschulschrift |2 gnd-content | |
| 689 | 0 | 0 | |a Hepatitis C |0 (DE-588)4262007-7 |D s |
| 689 | 0 | 1 | |a Kombinationstherapie |0 (DE-588)4194534-7 |D s |
| 689 | 0 | 2 | |a Interferon |g alpha-2a- |0 (DE-588)4353085-0 |D s |
| 689 | 0 | 3 | |a Amantadin |0 (DE-588)4201880-8 |D s |
| 689 | 0 | |5 DE-604 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-013142719 | ||
Datensatz im Suchindex
| _version_ | 1804133318595182592 |
|---|---|
| any_adam_object | |
| author | Matzner, Tobias 1976- |
| author_GND | (DE-588)129939595 |
| author_facet | Matzner, Tobias 1976- |
| author_role | aut |
| author_sort | Matzner, Tobias 1976- |
| author_variant | t m tm |
| building | Verbundindex |
| bvnumber | BV019817395 |
| classification_tum | MED 970d MED 403d MED 430d |
| ctrlnum | (OCoLC)163395264 (DE-599)BVBBV019817395 |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01425nam a2200409 c 4500</leader><controlfield tag="001">BV019817395</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20060220 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">050520s2004 d||| m||| 00||| ger d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)163395264</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV019817395</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">ger</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-91</subfield><subfield code="a">DE-12</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">MED 970d</subfield><subfield code="2">stub</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">MED 403d</subfield><subfield code="2">stub</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">MED 430d</subfield><subfield code="2">stub</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Matzner, Tobias</subfield><subfield code="d">1976-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)129939595</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Therapie der chronischen Hepatitis C mit Interferon alpha 2a und Amantadin</subfield><subfield code="c">Tobias Matzner</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2004</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">IV, 128 Bl.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">München, Techn. Univ., Diss., 2004</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Amantadin</subfield><subfield code="0">(DE-588)4201880-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Interferon</subfield><subfield code="g">alpha-2a-</subfield><subfield code="0">(DE-588)4353085-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Hepatitis C</subfield><subfield code="0">(DE-588)4262007-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Kombinationstherapie</subfield><subfield code="0">(DE-588)4194534-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4113937-9</subfield><subfield code="a">Hochschulschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Hepatitis C</subfield><subfield code="0">(DE-588)4262007-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Kombinationstherapie</subfield><subfield code="0">(DE-588)4194534-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Interferon</subfield><subfield code="g">alpha-2a-</subfield><subfield code="0">(DE-588)4353085-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Amantadin</subfield><subfield code="0">(DE-588)4201880-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-013142719</subfield></datafield></record></collection> |
| genre | (DE-588)4113937-9 Hochschulschrift gnd-content |
| genre_facet | Hochschulschrift |
| id | DE-604.BV019817395 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T20:06:49Z |
| institution | BVB |
| language | German |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-013142719 |
| oclc_num | 163395264 |
| open_access_boolean | |
| owner | DE-91 DE-BY-TUM DE-12 |
| owner_facet | DE-91 DE-BY-TUM DE-12 |
| physical | IV, 128 Bl. graph. Darst. |
| publishDate | 2004 |
| publishDateSearch | 2004 |
| publishDateSort | 2004 |
| record_format | marc |
| spelling | Matzner, Tobias 1976- Verfasser (DE-588)129939595 aut Therapie der chronischen Hepatitis C mit Interferon alpha 2a und Amantadin Tobias Matzner 2004 IV, 128 Bl. graph. Darst. txt rdacontent n rdamedia nc rdacarrier München, Techn. Univ., Diss., 2004 Amantadin (DE-588)4201880-8 gnd rswk-swf Interferon alpha-2a- (DE-588)4353085-0 gnd rswk-swf Hepatitis C (DE-588)4262007-7 gnd rswk-swf Kombinationstherapie (DE-588)4194534-7 gnd rswk-swf (DE-588)4113937-9 Hochschulschrift gnd-content Hepatitis C (DE-588)4262007-7 s Kombinationstherapie (DE-588)4194534-7 s Interferon alpha-2a- (DE-588)4353085-0 s Amantadin (DE-588)4201880-8 s DE-604 |
| spellingShingle | Matzner, Tobias 1976- Therapie der chronischen Hepatitis C mit Interferon alpha 2a und Amantadin Amantadin (DE-588)4201880-8 gnd Interferon alpha-2a- (DE-588)4353085-0 gnd Hepatitis C (DE-588)4262007-7 gnd Kombinationstherapie (DE-588)4194534-7 gnd |
| subject_GND | (DE-588)4201880-8 (DE-588)4353085-0 (DE-588)4262007-7 (DE-588)4194534-7 (DE-588)4113937-9 |
| title | Therapie der chronischen Hepatitis C mit Interferon alpha 2a und Amantadin |
| title_auth | Therapie der chronischen Hepatitis C mit Interferon alpha 2a und Amantadin |
| title_exact_search | Therapie der chronischen Hepatitis C mit Interferon alpha 2a und Amantadin |
| title_full | Therapie der chronischen Hepatitis C mit Interferon alpha 2a und Amantadin Tobias Matzner |
| title_fullStr | Therapie der chronischen Hepatitis C mit Interferon alpha 2a und Amantadin Tobias Matzner |
| title_full_unstemmed | Therapie der chronischen Hepatitis C mit Interferon alpha 2a und Amantadin Tobias Matzner |
| title_short | Therapie der chronischen Hepatitis C mit Interferon alpha 2a und Amantadin |
| title_sort | therapie der chronischen hepatitis c mit interferon alpha 2a und amantadin |
| topic | Amantadin (DE-588)4201880-8 gnd Interferon alpha-2a- (DE-588)4353085-0 gnd Hepatitis C (DE-588)4262007-7 gnd Kombinationstherapie (DE-588)4194534-7 gnd |
| topic_facet | Amantadin Interferon alpha-2a- Hepatitis C Kombinationstherapie Hochschulschrift |
| work_keys_str_mv | AT matznertobias therapiederchronischenhepatitiscmitinterferonalpha2aundamantadin |